Absence or deficit of FMR1 protein (FMRP) resulting from methylation of ful
l mutation genes is the fundamental defect in fragile X syndrome. We used F
MRP immunocytochemistry and detailed phenotypic assessment to investigate t
he relationship between degree of FMRP expression and the broad clinical sp
ectrum of impairment in 80 individuals affected with fragile X syndrome. FM
RP expression correlated with IQ in mosaic males (P=0.043), males with a pa
rtially methylated full mutation (P=0.0005), and females with a full mutati
on (P=0.046). In the females, FMRP expression also correlated with the numb
er of fragile X physical features (P=0.0003). Even modest deficits in FMRP
result in some manifestations of fragile X syndrome. In this initial study
of 53 males, FMRP expression testing had a very high positive predictive va
lue (100%, confidence interval of 29-100%) for a nonretarded IQ among males
with expression of FMRP in greater than or equal to 50% of lymphocytes (3
males), suggesting that FMRP expression may have potential as a prognostic
indicator in males with fragile X syndrome. (C) 1999 Wiley-Liss, Inc.